Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Pharmadrug Inc
C.PHRX
Alternate Symbol(s):
LMLLF
Medical Care
Cannabis
PharmaDrug Inc. is a Canada-based specialty pharmaceutical company. The Company is focused on the research, development and commercialization of controlled-substances and natural medicines, such as psychedelics and previously approved drugs. The Company’s subsidiary, Sairiyo Therapeutics (Sairiyo), is a biotech company that specializes in researching and reformulating established natural...
medicines. Sairiyo is engaged in the development of its patented reformulation of cepharanthine, a drug that has shown substantial third party validated potential for the treatment of infectious diseases and rare cancers. Sairiyo is also conducting research and development (R&D) in the psychedelics space for the treatment of non-neuropsychiatric conditions. The Company also operates through SecureDose Synthetics Inc., which is a pharmaceutical research and development company focused on the development of synthetic formulations of existing drugs for potential commercialization and distribution.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:PHRX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(6)
•••
Tommyjohn
X
View Profile
View Bullboard History
Post by
Tommyjohn
on Nov 20, 2024 9:45pm
Selling
What's with the sell off today
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Nov 15, 2024 5:31pm
New Press Release - PharmaDrug Announces Issuance of Debenture Units
Toronto, Ontario--(Newsfile Corp. - November 15, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines and naturally...
read article.
(6)
•••
Tommyjohn
X
View Profile
View Bullboard History
Comment by
Tommyjohn
on Nov 01, 2024 12:10am
RE:RE:RE:New debenture raise..to replace current debenture..!
Wow, great information, I really appreciate the insight.
(192)
•••
Guytorule
X
View Profile
View Bullboard History
Comment by
Guytorule
on Oct 31, 2024 10:43pm
RE:RE:New debenture raise..to replace current debenture..!
Markets play to their own tune. Typical market trading moves bringing in substantial buying volume and later retraces back to its start. It brings in new investors and outs old stagnate investors (Old
...more
(6)
•••
Tommyjohn
X
View Profile
View Bullboard History
Comment by
Tommyjohn
on Oct 31, 2024 9:30pm
RE:New debenture raise..to replace current debenture..!
Yes, does seem like good news, but are they not still short on cash. Still can't figure out the spike a few months back, just to fall flat. Is there no short terms catalysts in the works
...more
(192)
•••
Guytorule
X
View Profile
View Bullboard History
Post by
Guytorule
on Oct 31, 2024 7:50pm
New debenture raise..to replace current debenture..!
Good news, just released new debenture raise to replace current outstanding debenture due. Conversion possible within 1 year at a share price of .05 cents. All good, and with other good news today
...more
(12)
•••
RBLComm
X
View Profile
View Bullboard History
Post by
RBLComm
on Oct 31, 2024 4:35pm
NEWS: PharmaDrug’s Sairiyo Therapeutics Announces ....
PharmaDrug’s Sairiyo Therapeutics Announces Successful Completion of Stability Study of PD-001 (Patented Reformulated Cepharanthine) to Support Use in Phase 1 Study for Viral Infectious Diseases READ
...more
(192)
•••
Guytorule
X
View Profile
View Bullboard History
Comment by
Guytorule
on Sep 23, 2024 5:55pm
RE:Diggings...Market Cap. a Meagre $2 million
Agree, it's a buy at this price..only thing is, when do they do PP and at what price. They are very low on cash. We may see it happen very soon. Thought we could see a Placement at .08 cents or so
...more
(9)
•••
ezemoney
X
View Profile
View Bullboard History
Post by
ezemoney
on Sep 22, 2024 6:44pm
Diggings...Market Cap. a Meagre $2 million
I've been doing DD over the weekend, going through the company website, the executive, etc. It appears to me to be a very good executive team with well laid out plans and very good
...more
(6)
•••
Tommyjohn
X
View Profile
View Bullboard History
Post by
Tommyjohn
on Sep 20, 2024 1:49pm
News release
I would have expected some more excitement with yesterday's release!
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 19, 2024 8:02am
New Press Release - PharmaDrug's Sairiyo Therapuetics Announces Initiation of Study Start-Up Activities and Design for Clinical Trial of PD-001 (Patented Reformulated Cepharanthine) for Viral Infectious Diseases
Toronto, Ontario--(Newsfile Corp. - September 19, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Aug 28, 2024 8:01am
New Press Release - PharmaDrug's Sairiyo Therapuetics Provides Strategic Plans to Advance PD-001 (Patented Reformulated Cepharanthine) for Viral Infectious Diseases
Toronto, Ontario--(Newsfile Corp. - August 28, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics and...
read article.
(6)
•••
Tommyjohn
X
View Profile
View Bullboard History
Comment by
Tommyjohn
on Aug 26, 2024 10:49pm
RE:RE:RE:RE:Normal Course Action Likely Coming
Thanks for the insight, greatly appreciated.
(192)
•••
Guytorule
X
View Profile
View Bullboard History
Comment by
Guytorule
on Aug 26, 2024 7:54pm
RE:RE:RE:Normal Course Action Likely Coming
Markets beat to their own drum. The IPO is part of 49% owner PharmaTher (PHRM) Investor Presentation. It's stated to occur Q-4 this year and also states under their financing agreement can acquire
...more
(6)
•••
Tommyjohn
X
View Profile
View Bullboard History
Comment by
Tommyjohn
on Aug 26, 2024 5:56pm
RE:RE:Normal Course Action Likely Coming
Shouldn't this drive up the price and when are we expecting this to take place.I
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >